Dexmedetomidine Combined With Patient-Controlled Analgesia for Palliative Sedation in Terminal-Stage Cancer Patients With Refractory Pain: A Retrospective Analysis of Nine Cases
Conclusion: DEX emerges as a promising option for palliative sedation in terminal-stage cancer patients. When used in conjunction with PCA, DEX has been shown to effectively, safely, and stably control refractory pain without inducing adverse effects such as respiratory/circulatory depression.
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2024-01-01
|
| Series: | Pain Research and Management |
| Online Access: | http://dx.doi.org/10.1155/2024/4707707 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832557937331011584 |
|---|---|
| author | Na Li Yumei Wang Meng Cui |
| author_facet | Na Li Yumei Wang Meng Cui |
| author_sort | Na Li |
| collection | DOAJ |
| description | Conclusion: DEX emerges as a promising option for palliative sedation in terminal-stage cancer patients. When used in conjunction with PCA, DEX has been shown to effectively, safely, and stably control refractory pain without inducing adverse effects such as respiratory/circulatory depression. |
| format | Article |
| id | doaj-art-f57dd60aae974feb992fc1031f31d2d4 |
| institution | Kabale University |
| issn | 1918-1523 |
| language | English |
| publishDate | 2024-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Pain Research and Management |
| spelling | doaj-art-f57dd60aae974feb992fc1031f31d2d42025-02-03T01:47:19ZengWileyPain Research and Management1918-15232024-01-01202410.1155/2024/4707707Dexmedetomidine Combined With Patient-Controlled Analgesia for Palliative Sedation in Terminal-Stage Cancer Patients With Refractory Pain: A Retrospective Analysis of Nine CasesNa Li0Yumei Wang1Meng Cui2Department of Hospice CareDepartment of Hospice CareDepartment of Hospice CareConclusion: DEX emerges as a promising option for palliative sedation in terminal-stage cancer patients. When used in conjunction with PCA, DEX has been shown to effectively, safely, and stably control refractory pain without inducing adverse effects such as respiratory/circulatory depression.http://dx.doi.org/10.1155/2024/4707707 |
| spellingShingle | Na Li Yumei Wang Meng Cui Dexmedetomidine Combined With Patient-Controlled Analgesia for Palliative Sedation in Terminal-Stage Cancer Patients With Refractory Pain: A Retrospective Analysis of Nine Cases Pain Research and Management |
| title | Dexmedetomidine Combined With Patient-Controlled Analgesia for Palliative Sedation in Terminal-Stage Cancer Patients With Refractory Pain: A Retrospective Analysis of Nine Cases |
| title_full | Dexmedetomidine Combined With Patient-Controlled Analgesia for Palliative Sedation in Terminal-Stage Cancer Patients With Refractory Pain: A Retrospective Analysis of Nine Cases |
| title_fullStr | Dexmedetomidine Combined With Patient-Controlled Analgesia for Palliative Sedation in Terminal-Stage Cancer Patients With Refractory Pain: A Retrospective Analysis of Nine Cases |
| title_full_unstemmed | Dexmedetomidine Combined With Patient-Controlled Analgesia for Palliative Sedation in Terminal-Stage Cancer Patients With Refractory Pain: A Retrospective Analysis of Nine Cases |
| title_short | Dexmedetomidine Combined With Patient-Controlled Analgesia for Palliative Sedation in Terminal-Stage Cancer Patients With Refractory Pain: A Retrospective Analysis of Nine Cases |
| title_sort | dexmedetomidine combined with patient controlled analgesia for palliative sedation in terminal stage cancer patients with refractory pain a retrospective analysis of nine cases |
| url | http://dx.doi.org/10.1155/2024/4707707 |
| work_keys_str_mv | AT nali dexmedetomidinecombinedwithpatientcontrolledanalgesiaforpalliativesedationinterminalstagecancerpatientswithrefractorypainaretrospectiveanalysisofninecases AT yumeiwang dexmedetomidinecombinedwithpatientcontrolledanalgesiaforpalliativesedationinterminalstagecancerpatientswithrefractorypainaretrospectiveanalysisofninecases AT mengcui dexmedetomidinecombinedwithpatientcontrolledanalgesiaforpalliativesedationinterminalstagecancerpatientswithrefractorypainaretrospectiveanalysisofninecases |